169 related articles for article (PubMed ID: 18465169)
1. Comparative proteomic analysis of non-small-cell lung cancer and normal controls using serum label-free quantitative shotgun technology.
Pan J; Chen HQ; Sun YH; Zhang JH; Luo XY
Lung; 2008; 186(4):255-261. PubMed ID: 18465169
[TBL] [Abstract][Full Text] [Related]
2. Lung cancer serum biomarker discovery using glycoprotein capture and liquid chromatography mass spectrometry.
Zeng X; Hood BL; Sun M; Conrads TP; Day RS; Weissfeld JL; Siegfried JM; Bigbee WL
J Proteome Res; 2010 Dec; 9(12):6440-9. PubMed ID: 20931982
[TBL] [Abstract][Full Text] [Related]
3. In-depth proteomic analysis of nonsmall cell lung cancer to discover molecular targets and candidate biomarkers.
Kikuchi T; Hassanein M; Amann JM; Liu Q; Slebos RJ; Rahman SM; Kaufman JM; Zhang X; Hoeksema MD; Harris BK; Li M; Shyr Y; Gonzalez AL; Zimmerman LJ; Liebler DC; Massion PP; Carbone DP
Mol Cell Proteomics; 2012 Oct; 11(10):916-32. PubMed ID: 22761400
[TBL] [Abstract][Full Text] [Related]
4. Identification of GlcNAcylated alpha-1-antichymotrypsin as an early biomarker in human non-small-cell lung cancer by quantitative proteomic analysis with two lectins.
Jin Y; Wang J; Ye X; Su Y; Yu G; Yang Q; Liu W; Yu W; Cai J; Chen X; Liang Y; Chen Y; Wong BH; Fu X; Sun H
Br J Cancer; 2016 Mar; 114(5):532-44. PubMed ID: 26908325
[TBL] [Abstract][Full Text] [Related]
5. Comparative serum proteome analysis of human lymph node negative/positive invasive ductal carcinoma of the breast and benign breast disease controls via label-free semiquantitative shotgun technology.
Hu X; Zhang Y; Zhang A; Li Y; Zhu Z; Shao Z; Zeng R; Xu LX
OMICS; 2009 Aug; 13(4):291-300. PubMed ID: 19624269
[TBL] [Abstract][Full Text] [Related]
6. In-depth proteomic analysis of six types of exudative pleural effusions for nonsmall cell lung cancer biomarker discovery.
Liu PJ; Chen CD; Wang CL; Wu YC; Hsu CW; Lee CW; Huang LH; Yu JS; Chang YS; Wu CC; Yu CJ
Mol Cell Proteomics; 2015 Apr; 14(4):917-32. PubMed ID: 25638566
[TBL] [Abstract][Full Text] [Related]
7. Tumor-derived exosomal proteins as diagnostic biomarkers in non-small cell lung cancer.
Niu L; Song X; Wang N; Xue L; Song X; Xie L
Cancer Sci; 2019 Jan; 110(1):433-442. PubMed ID: 30407700
[TBL] [Abstract][Full Text] [Related]
8. Integrative proteomics and tissue microarray profiling indicate the association between overexpressed serum proteins and non-small cell lung cancer.
Liu Y; Luo X; Hu H; Wang R; Sun Y; Zeng R; Chen H
PLoS One; 2012; 7(12):e51748. PubMed ID: 23284758
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer.
Yildiz PB; Shyr Y; Rahman JS; Wardwell NR; Zimmerman LJ; Shakhtour B; Gray WH; Chen S; Li M; Roder H; Liebler DC; Bigbee WL; Siegfried JM; Weissfeld JL; Gonzalez AL; Ninan M; Johnson DH; Carbone DP; Caprioli RM; Massion PP
J Thorac Oncol; 2007 Oct; 2(10):893-901. PubMed ID: 17909350
[TBL] [Abstract][Full Text] [Related]
10. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
[TBL] [Abstract][Full Text] [Related]
12. Lung cancer serum biomarker discovery using label-free liquid chromatography-tandem mass spectrometry.
Zeng X; Hood BL; Zhao T; Conrads TP; Sun M; Gopalakrishnan V; Grover H; Day RS; Weissfeld JL; Wilson DO; Siegfried JM; Bigbee WL
J Thorac Oncol; 2011 Apr; 6(4):725-34. PubMed ID: 21304412
[TBL] [Abstract][Full Text] [Related]
13. LC-MS/MS-Based Quantitative Proteomics Analysis of Different Stages of Non-Small-Cell Lung Cancer.
Zhou M; Kong Y; Wang X; Li W; Chen S; Wang L; Wang C; Zhang Q
Biomed Res Int; 2021; 2021():5561569. PubMed ID: 33728331
[TBL] [Abstract][Full Text] [Related]
14. Unique Protein Profiles of Extracellular Vesicles as Diagnostic Biomarkers for Early and Advanced Non-Small Cell Lung Cancer.
An T; Qin S; Sun D; Huang Y; Hu Y; Li S; Zhang H; Li B; Situ B; Lie L; Wu Y; Zheng L
Proteomics; 2019 Jun; 19(12):e1800160. PubMed ID: 30950185
[TBL] [Abstract][Full Text] [Related]
15. Detection and identification of potential biomarkers of non-small cell lung cancer.
Yang Y; Zhao S; Fan Y; Zhao F; Liu Q; Hu W; Liu D; Fan K; Wang J; Wang J
Technol Cancer Res Treat; 2009 Dec; 8(6):455-66. PubMed ID: 19925029
[TBL] [Abstract][Full Text] [Related]
16. Proteome analysis of non-small cell lung cancer cell line secretomes and patient sputum reveals biofluid biomarker candidates for cisplatin response prediction.
Böttger F; Schaaij-Visser TB; de Reus I; Piersma SR; Pham TV; Nagel R; Brakenhoff RH; Thunnissen E; Smit EF; Jimenez CR
J Proteomics; 2019 Mar; 196():106-119. PubMed ID: 30710758
[TBL] [Abstract][Full Text] [Related]
17. Nested case control study of proteomic biomarkers for interstitial lung disease in Japanese patients with non-small-cell lung cancer treated with erlotinib: a multicenter phase IV study (JO21661).
Atagi S; Katakami N; Yoshioka H; Fukuoka M; Kudoh S; Ogiwara A; Imai M; Ueda M; Matsui S
Clin Lung Cancer; 2013 Jul; 14(4):407-17. PubMed ID: 23490546
[TBL] [Abstract][Full Text] [Related]
18. [Preliminary Study on the Biological Markers for I-IIb Stage Non-small Cell Lung Cancer Based on a Serum-peptidomics].
Hou Y; Guo H; Guo Y; Zhang Y; Han H
Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):20-25. PubMed ID: 30674389
[TBL] [Abstract][Full Text] [Related]
19. Cortisol, cortisone, and 4-methoxyphenylacetic acid as potential plasma biomarkers for early detection of non-small cell lung cancer.
Xiang C; Jin S; Zhang J; Chen M; Xia Y; Shu Y; Guo R
Int J Biol Markers; 2018 Aug; 33(3):314-320. PubMed ID: 29896992
[TBL] [Abstract][Full Text] [Related]
20. Label-free quantitative proteomics and N-terminal analysis of human metastatic lung cancer cells.
Min H; Han D; Kim Y; Cho JY; Jin J; Kim Y
Mol Cells; 2014 Jun; 37(6):457-66. PubMed ID: 24805778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
